Katie Smith
Medical · Mauldin, SCNPI 1588905624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $570 and has fallen 97.1% since, to $17 in 2023. That places this record below the midpoint for medical clinicians in SC, where the typical reported total is $906.
Across 41 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$81
- Amarin Pharma, Inc.$80
- Amgen$46
- AbbVie$41
- Biohaven Pharmaceuticals, Inc.$39
- Takeda Pharmaceuticals U.S.A., Inc.$31
- plus $284 from 17 others
What the payments were for
- Food & beverage$58797%
- Other$153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 5 | $81 |
| Amarin Pharma, Inc. | 5 | $80 |
| Amgen | 3 | $46 |
| AbbVie | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Novartis | 2 | $31 |
| Johnson & Johnson | 2 | $29 |
| Eisai Inc. | 2 | $27 |
| Pfizer | 2 | $25 |
| GSK | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Edwards Lifesciences | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
| Forte Bio-pharma LLC | 1 | $7 |
How this compares
$603 in reported general payments places this provider in the 40th percentile of 384 medical providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $181 |
| Prednisone | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other medical in Mauldin
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
- Cameron PappasGreenville$18K
- Leslie RumbautGrenville$18K
- Claire DukeGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.